Evidence map›Paper›PMID 30862755›Full record

ArticlemBio2019

Novel Intersubunit Interaction Critical for HIV-1 Core Assembly Defines a Potentially Targetable Inhibitor Binding Pocket.

Pierrick Craveur, Anna T Gres, Karen A Kirby, Dandan Liu, John A Hammond, Yisong Deng, Stefano Forli, David S Goodsell, James R Williamson, Stefan G Sarafianos and 1 more

Abstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. The AutoDock suite at 30.Protein science : a publication of the Protein Society · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. HIV Capsid Inhibitors Beyond PF74.Diseases (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pierrick CraveurDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Anna T GresChristopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
Karen A KirbyChristopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
Dandan LiuChristopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
John A HammondDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Yisong DengDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Stefano ForliDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
David S GoodsellDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
James R WilliamsonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Stefan G SarafianosChristopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA stefanos.sarafianos@emory.edu olson@scripps.edu.
Arthur J OlsonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA stefanos.sarafianos@emory.edu olson@scripps.edu.

Funding

Project 9P50GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ARNOLD, EDWARD · 2012 to 2016
$20.0M
X-ray Crystallographic Fragment Screening CoreU54AI150472 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI LYUMKIS, DMITRY · 2019 to 2021
$15.7M
X-ray Crystallographic Fragment Screening CoreU54GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SARAFIANOS, STEFAN G, TORBETT, BRUCE EDWARD · 2017 to 2018
$11.1M
Structural studies of HIV Capsid with host factors and Capsid-targeting antiviralsR01AI120860 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI Stefan G Sarafianos, Zhengqiang Wang · 2015 to 2026
$6.0M
NIAID NIH HHS R01 AI120860NIAID NIH HHS U54 AI150472NIGMS NIH HHS P50 GM103368NIGMS NIH HHS U54 GM103368
6 · The paper itself

Abstract

HIV-1 capsid protein (CA) plays critical roles in both early and late stages of the viral replication cycle. Mutagenesis and structural experiments have revealed that capsid core stability significantly affects uncoating and initiation of reverse transcription in host cells. This has led to efforts in developing antivirals targeting CA and its assembly, although none of the currently identified compounds are used in the clinic for treatment of HIV infection. A specific interaction that is primarily present in pentameric interfaces in the HIV-1 capsid core was identified and is reported to be important for CA assembly. This is shown by multidisciplinary characterization of CA site-directed mutants using biochemical analysis of virus-like particle formation, transmission electron microscopy of

Indexed as

Protein MultimerizationVirus AssemblyCapsidCrystallography, X-RayDNA Mutational AnalysisHIV-1HIV Core Protein p24Microscopy, Electron, TransmissionMolecular Dynamics SimulationProtein BindingProtein Interaction MappingHIV Core Protein p24capsidcapsid assemblycomputer modelinghuman immunodeficiency virusX-ray crystallography

Identifiers

PMID30862755
PMCPMC6414707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.